Oncozenge AB

Research Oncozenge AB (ONCOZ) on Bullrun: market cap SEK 101.41M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerONCOZ
ExchangeST
CountrySweden
SectorHealthcare
IndustryBiotechnology
CurrencySEK
Market capSEK 101.41M
Financial periodQ1 2026
RevenueSEK 0
Net income-SEK 7.13M
Free cash flow-SEK 10.85M

Valuation Snapshot

latest market cap is SEK 101.41M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	SEK 2.71M	-SEK 15.94M	n/a	104.3%	n/a	SEK 3.71M	SEK 7.50M	SEK 8.48M
FY2024	SEK 0	-SEK 8.68M	n/a	n/a	n/a	SEK 3.86M	n/a	SEK 9.95M
FY2023	SEK 0	-SEK 15.90M	n/a	n/a	n/a	SEK 12.63M	n/a	n/a
FY2022	n/a	-SEK 46.65M	n/a	n/a	n/a	SEK 29.14M	n/a	n/a

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-23	SEK 101.41M	n/a	n/a	n/a

About Oncozenge AB

OncoZenge AB (publ), is a clinical-stage pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden. The company offers BupiZenge, which is in Phase 3 clinical trials for the treatment of pain in the oral cavity. The company was founded in 2020 and is headquartered in Bromma, Sweden.

Related stock research

Sweden stocks Sweden Healthcare stocks A-Z stock index

Other Healthcare stocks

Camurus AB (0RD1) Flerie AB (publ) (1NP1) GENOVIS AB SE-40 (5GV) Fluicell AB (publ) (5J90) ExpreS2ion Biotech Holding AB (publ) (5JD0) ALZINOVA AB (78D) 7AL0 (7AL0) ASCELIA PHARMA AB (7ZA) Biosergen AB (8N10) ABERA BIOSCIENCE AB (8WK) Ascelia Pharma AB (publ) (ACE) AcouSort AB (ACOU)

Frequently asked questions

What is Oncozenge AB's market cap?

Oncozenge AB's market capitalization is SEK 101.41M.